China Shenghuo Announces Settlement Agreement for Class Action Lawsuit

China Shenghuo Pharmaceutical Holdings, Inc. KUN announced today the final approval by the court of a settlement agreement resolving and dismissing all claims asserted against the company in the consolidated class action lawsuit, Varghese, et al v. China Shenghuo Pharmaceutical Holdings, Inc., et al. The substantive allegations of the amended consolidated complaint have previously been summarized in SEC disclosures by China Shenghuo. China Shenghuo is contributing US $200,000 towards a total settlement fund of $600,000.